Definitive Contract 75D30120C07976
Award Date 4/30/20
Potential Completion Date 4/28/21
Potential Value $370K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Westbury, NY 11590, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded to Bioivt, LLC by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services. The $18,575 contract is for the delivery of AD HUMAN CSF and has a period of performance through November 8, 2024. Bioivt is a leading global provider of biological specimens and value-added services, and has previously supported medical research programs across various federal agencies through prime...
- The U.S. Department of Veterans Affairs (VA) awarded a $310,551.59 firm fixed-price purchase order contract to Bioreference Health LLC, a for-profit limited liability company that provides laboratory testing services, including COVID-19 serology testing in support of the Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) response efforts. This award has no set-aside designation and is scheduled for completion by May 27, 2024. Bioreference Health...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $5,760,000.00 definitive, firm fixed-price contract to Bioreference Health LLC for serology testing services. This contract is not designated as a set-aside. Through this contract, Bioreference Health, a subsidiary of Opko Health, Inc., is providing COVID-19 serology testing services to support the CDC's disease surveillance and public health laboratory testing programs. Bioreference...
- The Centers for Disease Control and Prevention's Pittsburgh office awarded a $15,000 firm fixed-price purchase order to Bioivt, LLC for the procurement of human urine specimens. The contract, awarded on September 13, 2024, with an ultimate completion date of November 1, 2024, was competitively awarded with no set-aside designation. Performance will take place in Atlanta, Georgia. Bioivt, LLC, a leading supplier of high-quality biological specimens headquartered in Westbury, New York, specializes...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bioivt, LLC for the purchase of cryopreserved hepatocytes. The contract has a ceiling value of $16,179.20 and a completion date of August 16, 2024. Bioivt, LLC is a leading global provider of high-quality biological specimens and value-added services, with experience delivering similar products to federal agencies including the Defense Health Agency, Army Medical Command, National Institutes of Health,...
- This federal contract award to Bioivt, LLC, a for-profit limited liability company based in Westbury, New York, is for the Acquisition of Cynomologous Monkey Cryoplateable Hepatocytes. The $42,000.00 Firm Fixed Price Delivery Order contract was awarded by the Defense Health Agency, a defense agency, and has an ultimate completion date of August 11, 2025. This award was not set aside for any specific business designation. Bioivt, LLC is a leading global provider of biological materials and has...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $396,400 firm-fixed-price definitive contract to Stemexpress, LLC (doing business as CGT Global), a woman-owned small business. The contract is for the delivery of COVID-19 positive serum samples. Stemexpress is a provider of human biological samples and specimen collection services for research and development in the life sciences. The company has previously supplied items to the Food and Drug...
- This federal contract award is for the delivery of COVID-19 convalescent serum by Blood Centers of America, Inc. (BCA), a for-profit organization, to the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract has a firm fixed price of $75,000.00 and a completion date of November 24, 2020. No set-aside designation is noted. Additionally, BCA has received over $6 million in prime federal contracts from the...
- This cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention to Vitalant Research Institute to characterize the seroprevalence of SARS-CoV-2 antibodies in the U.S. population through May 2024. The $46.4 million contract expands Vitalant's ongoing work under the National SARS-CoV-2 Seroincidence Studies in Blood Donors contract to provide additional longitudinal data on antibody stability and reinfection risk through testing approximately 130,000 blood donors....
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to Bioivt, LLC, a for-profit limited liability company, to provide COVID-19 positive blood serum. The Firm Fixed Price contract, valued at $370,350.00, has a completion date of April 28, 2021. Bioivt, LLC is a leading global provider of high-quality biological specimens and has previously supported various medical research programs across federal agencies, including the Defense Health Agency, Army Medical Command, National Institutes of Health, Food and Drug Administration, and Centers for Disease Control and Prevention. The contract is not associated with a set-aside program.
Generated 3/21/24, 11:31 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 3/30/23 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 5/21/20 | |
| Not listed | Not listed | $155.5k | 4/30/20 |